Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N-(6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl)-5-chloro-1-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-1H-indole-3-carboxamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N-(6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl)-5-chloro-1-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-1H-indole-3-carboxamide
Unique ID
C000593223
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000593223
Entry Term(s)
SAR216471
Registry Numbers
0
Heading Mapped to
*Indoles
*Pyridazines
Frequency
2
Note
a platelet aggregation inhibitor with P2Y12 antagonist activity; structure in first source
Source
J Med Chem. 2014 Sep 11;57(17):7293-316.
Date of Entry
2014/11/28
Revision Date
2014/11/28
N-(6-(4-butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl)-5-chloro-1-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)-1H-indole-3-carboxamide Preferred
SAR216471 Narrower
page delivered in 0.007s